Inovio Pharma (INO) Misses Q2 EPS by 119c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.25 -3.85%
Financial Fact:
License fee and milestone revenue from affiliated entity: 574.6K
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
License fee and milestone revenue from affiliated entity: 574.6K
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($1.19). Revenue for the quarter came in at $100 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent on Iran: maximum economic pressure means likely not a kinetic restart
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
